| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 78,191 | 81,554 | 78,561 | 78,574 | | Cost of Revenue | 35,870 | 37,452 | 42,024 | 43,318 | | | Gross Profit | 42,321 | 44,102 | 36,537 | 35,256 | | | Operating Expenses | | Research Development | 18,764 | 20,361 | 21,283 | 25,384 | | Selling General and Administrative | 30,608 | 31,686 | 33,982 | 34,379 | | Non Recurring | (296) | 226 | 1,967 | 253,726 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,755) | (8,171) | (20,695) | (278,233) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 774 | 17,597 | 366 | 3,799 | | Earnings Before Interest And Taxes | (5,981) | 10,632 | (21,535) | (274,434) | | Interest Expense | 2,430 | 2,903 | 3,177 | 3,457 | | Income Before Tax | (8,411) | 7,729 | (24,712) | (277,891) | | Income Tax Expense | 408 | 409 | 493 | 40,825 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,819) | 7,320 | (25,205) | (318,716) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,819) | 7,320 | (25,205) | (318,716) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,819) | $7,320 | ($25,205) | ($318,716) |
|
0.03% Nasdaq 0.00%
Income Statement
